Sema4 Holdings Corp. (SMFR) Q4 2021 Earnings Conference Call March 14, 2022 4:30 PM ET Company Participants Joel Kaufman - VP Finance & Corporate Development Eric Schadt - Founder and Chief Executive Officer Isaac Ro - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Max Masucci - Cowen & Company Mark Massaro - BTIG Dave Delahunt - Goldman Sachs Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within ...

sema4 Q4 2021 Earnings Presentation March 2022 Disclaimer This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, for example, contain wording such as "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "objective," "anticipate," "believe," "estimate," "p ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 001-39482 Sema4 Holdings Corp. (Exact name of registrant as specified in its charter) Delaware 85 ...

sema4 Investor Presentation J.P. Morgan Healthcare Conference January 2022 Disclaimer This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, for example, contain wording such as "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "objective," "anticipate ...

sema4 Third Quarter 2021 Earnings Presentation . . . 2 Disclaimer This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, for example, contain wording such as "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "objective," "anticipate," "believe," "estim ...

Sema4 Holdings Corp. (SMFR) Q3 2021 Earnings Conference Call November 16, 2021 4:30 PM ET Company Participants Eric Schadt – Founder and Chief Executive Officer Joel Kaufman – VP Finance & Corporate Development Isaac Ro – Chief Financial Officer Conference Call Participants Brandon Couillard – Jefferies Max Masucci – Cowen Mark Massaro – BTIG Matt Sykes – Goldman Sachs Operator Good day, and thank you for standing by. Welcome to the Sema4 Third Quarter 2021 Earnings Conference Call. At this time, all partic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 001-39482 Sema4 Holdings Corp. (Exact name of registrant as specified in its charter) (State or other juri ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q c/o Corvex Management LP 667 Madison Avenue New York, New York 10065 (Address of Principal Executive Offices, including zip code) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39482 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 c/o Corvex Management LP 667 Madison Avenue New York, New York 10065 (Address of Principal Executive Offices, including zip code) (212) 474-6745 For the transition period from to Commission Fi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File No. 001-39482 CM Life Sciences, Inc. (Exact name of registrant as specified in its charter) | Delaware | | 85-1966622 | | ...